Showing results (2381-2390 of 4,138) with videos related to

Sort By:
Pageof 414
Human Gene Therapy|February 15, 2001
Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neuronsJ Fleming, S L Ginn, R P Weinberger, et al.
Human Gene Therapy|February 15, 2001
A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virusC Logvinoff, A L Epstein
Human Gene Therapy|February 15, 2001
Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophiesL Cordier, G P Gao, A A Hack, et al.
Human Gene Therapy|February 15, 2001
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trialB Wittig, A Märten, T Dorbic, et al.
Human Gene Therapy|February 15, 2001
Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cellsS Hacein-Bey, F Gross, P Nusbaum, et al.
Human Gene Therapy|January 26, 2000
Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysisP L Leopold, G Kreitzer, N Miyazawa, et al.
Human Gene Therapy|October 9, 1999
Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectorisD D Esakof, M Maysky, D W Losordo, et al.
Human Gene Therapy|October 9, 1999
Distribution of recombinant adenovirus in the cerebrospinal fluid of nonhuman primatesM J Driesse, J M Kros, C J Avezaat, et al.
Human Gene Therapy|August 14, 1999
Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioningR D Huhn, J F Tisdale, B Agricola, et al.
Human Gene Therapy|August 14, 1999
Acquired constitutive expression of interferon beta after gene transduction enhances human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity by a RANTES-dependent mechanismF Hadida, E De Maeyer, I Cremer, et al.
Pageof 414